-
Novartis research shows technology talent increasingly drawn to pharma industry since COVID-19, to solve healthcare challenges
worldpharmanews
June 29, 2020
Novartis revealed the healthcare and pharma industry has emerged as a desired career destination for tech talent during the COVID-19 pandemic, in the Powerful Pairing research report launched.
-
Study is first to identify potential therapeutic targets for COVID-19
worldpharmanews
June 29, 2020
A team from Lawson Health Research Institute and Western University are the first in the world to profile the body's immune response to COVID-19.
-
Lilly begins world's first study of a potential COVID-19 antibody treatment in humans
worldpharmanews
June 29, 2020
Eli Lilly and Company announced patients have been dosed in the world's first study of a potential antibody treatment designed to fight COVID-19.
-
Biomerica Files for EUA for its COVID-19 Laboratory Antibody Test
americanpharmaceuticalreview
June 29, 2020
Biomerica submitted an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administration (FDA) for an ELISA lab-based serology blood test for the detection of antibodies that identify if a person has been infected with ...
-
Pharma Packaging Companies Commit to Supply for Covid-19
americanpharmaceuticalreview
June 29, 2020
The CEOs of Gerresheimer, Stevanato Group, and SCHOTT are committed to ensuring ample supply of pharmaceutical containers for any Covid-19 vaccine and treatment that is developed.
-
PTC Announces the Phase 2/3 Clinical Trial to Evaluate PTC299 for COVID-19
americanpharmaceuticalreview
June 29, 2020
PTC Therapeutics announced the U.S. Food and Drug Administration (FDA) has authorized the initiation of a Phase 2/3 trial to investigate PTC299, a dihydroorotate dehydrogenase (DHODH) inhibitor, as a potential treatment for COVID-19.
-
Aethlon Announces FDA Approval of IDE Supplement for COVID-19 Patients
americanpharmaceuticalreview
June 29, 2020
Aethlon Medical announced the U.S. Food and Drug Administration (FDA) has approved a supplement to the Company's existing Investigational Device Exemption (IDE) for the Company's Hemopurifier? in viral disease to allow for the testing of ...
-
FDA Revokes Emergency Use Authorization for Chembio Antibody Test
americanpharmaceuticalreview
June 29, 2020
The U.S. Food and Drug Administration (FDA) has revoked the emergency use authorization (EUA) of the Chembio Diagnostic System DPP COVID-19 IgM/IgG System ...
-
Study identifies immune cells involved in protection against COVID-19
expresspharma
June 29, 2020
A study, published in the journal Science Immunology, assessed T cells from 10 COVID-19 patients under intensive care treatment.
-
Global COVID-19 fundraising meeting raises $6.9 billion, leaders want vaccine for all
expresspharma
June 29, 2020
The money will be used for COVID-19 tests, treatments and vaccines, and also to support the world’s poorest and most marginalised communities.